NEW YORK (GenomeWeb News) – Gentronix and Apredica said today that they will collaborate on providing drug-discovery support services with a focus on predictive toxicology.

Watertown, Mass.-based Apredica is an ADME-Tox contract research laboratory and has been working with Gentronix on developing "a joint predictive toxicology offering based on a set of assays that accurately predict many known mechanisms of human toxicities," the firm's president, Katya Tsaioun, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.